Digestive & Intestinal Remedies (Pharmacies) - Zambia

  • Zambia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$2.44m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.29%, resulting in a market volume of US$3.31m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.12 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Zambia has been experiencing steady growth in recent years.

Customer preferences:
Zambian consumers have shown a growing interest in digestive and intestinal remedies, leading to an increased demand for these products in pharmacies. This can be attributed to several factors, including changing dietary habits, increased awareness about digestive health, and a rise in gastrointestinal disorders among the population. Consumers are seeking effective and affordable solutions to address their digestive issues, and pharmacies have become a popular destination for purchasing these remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Zambia is the shift towards natural and herbal remedies. Many consumers are opting for products that are perceived to be more gentle on the digestive system and have fewer side effects. This has led to an increase in the availability of natural and herbal remedies in pharmacies, as well as a rise in the number of local and international brands offering such products. Another trend in the market is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are believed to help restore the natural balance of bacteria in the gut and alleviate symptoms of digestive disorders. As more consumers become aware of the benefits of probiotics, the demand for probiotic supplements and foods has been on the rise in Zambia. Pharmacies are stocking a wide range of probiotic products to cater to this growing demand.

Local special circumstances:
Zambia has a high prevalence of gastrointestinal diseases such as diarrhea, gastritis, and peptic ulcers. This can be attributed to factors such as poor sanitation, inadequate access to clean water, and limited healthcare facilities in rural areas. As a result, there is a significant need for digestive and intestinal remedies in the country. Pharmacies play a crucial role in providing these remedies to the population, especially in areas where access to healthcare facilities is limited.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies market in Zambia can also be attributed to macroeconomic factors such as population growth, urbanization, and increasing disposable incomes. As the population continues to grow and more people move to urban areas, the demand for healthcare products, including digestive and intestinal remedies, is expected to increase. Additionally, rising disposable incomes allow consumers to afford these products, further driving market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Zambia is experiencing steady growth due to changing customer preferences, including a shift towards natural and herbal remedies and the growing popularity of probiotics. The high prevalence of gastrointestinal diseases in the country, coupled with underlying macroeconomic factors such as population growth and increasing disposable incomes, are also contributing to the market's development. Pharmacies in Zambia are playing a vital role in meeting the demand for digestive and intestinal remedies, particularly in areas with limited access to healthcare facilities.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)